SCHEMBL4987364

SCHEMBL4987364

Clc1cccc(-c2cncc(N3CCN(c4ccncc4)CC3)n2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 1/20 0.48
HRH1 P35367 1/20 0.48
HRH3 Q9Y5N1 1/20 0.48
PIM2 Q9P1W9 9/20 0.45
RAD52 P43351 1/20 0.45
NPSR1 Q6W5P4 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
FYN P06241 1/20 0.44
CNR2 P34972 1/20 0.43
PIM1 P11309 1/20 0.42
CSNK2A2 P19784 1/20 0.42
CSNK2A1 P68400 1/20 0.42
CHRM1 P11229 1/20 0.42
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4996922 0.85 PIM2 (0.47) PIM2RAD52PIM1CSNK2A2CSNK2A1
SCHEMBL4997813 0.85 PIK3CA (0.55) PIM2RAD52FYNPIM1CSNK2A2
SCHEMBL4997537 0.85 CYP11B1 (0.46) PIM2RAD52ALDH1A1TP53FYN
SCHEMBL5003462 0.84 MAPT (0.47) HRH2HRH1HRH3NPSR1SMN1; SMN2
SCHEMBL4997181 0.84 MAPT (0.47) PIM2RAD52ALDH1A1TP53GAA
SCHEMBL4997412 0.84 KMT2A (0.55) PIM2RAD52NPSR1ALDH1A1TP53
SCHEMBL5000893 0.84 ABCG2 (0.52) PIM2ALDH1A1GAASMN1; SMN2LMNA
SCHEMBL4992156 0.83 CYP11B1 (0.49) PIM2RAD52PIM1CYP11B1CYP11B2
SCHEMBL4995459 0.82 CYP11B1 (0.48) PIM2RAD52CYP11B1CYP11B2
SCHEMBL5000651 0.82 RAD52 (0.47) PIM2RAD52SMN1; SMN2FYNPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194574-A1 Pyrazine Derivatives As Effective Compounds Against Infectious Diseases AXXIMA PHARMACEUTICALS AG (DE) 2008-08-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194574-A1 Pyrazine Derivatives As Effective Compounds Against Infectious Diseases PRNP, PSEN1, PPP5C HRH2 2616/4885HRH1 2393/4885HRH3 3459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.